Bamboo salt attenuates CCl4-induced hepatic damage in sprague-dawley rats

Nutrition Research and Practice

Volumn 7, Issue 4, 2013, Pages 273-280

  Zhao, Xin ^a,b   Song, Jia Le ^a   Kil, Jeung Ha ^a   Park, Kun Young ^a  

^a Pusan National University   (South Korea)

^b CHONGQING UNIVERSITY OF EDUCATION   (China)

Author keywords

Bamboo salt; CCl4; Cytokines; Hepatic damage; Inflammation

Indexed keywords

EID: 84882597911     PISSN: 19761457     EISSN: 20056168     Source Type: Journal    
DOI: 10.4162/nrp.2013.7.4.273     Document Type: Article

References (44)

1. Hu C, Zhang Y, Kitts DD. Evaluation of antioxidant and prooxidant activities of bamboo Phyllostachys nigra var. Henonis leaf extract in vitro. J Agric Food Chem 2000;48:3170-6.
2. Shin HY, Na HJ, Moon PD, Seo SW, Shin TY, Hong SH, Lee KN, Park RK, Kim HM. Biological activity of bamboo salt. Food Ind Nutr 2004;9:36-45.
3. Shin HY, Lee EH, Kim CY, Shin TY, Kim SD, Song YS, Lee KN, Hong SH, Kim HM. Anti-inflammatory activity of Korean folk medicine purple bamboo salt. Immunopharmacol Immunotoxicol 2003;25:377-84.
4. Cauwels A, Brouckaert P. Survival of TNF toxicity: dependence on caspases and NO. Arch Biochem Biophys 2007;462:132-9.
5. Seitz HK, Stickel F. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem 2006;387:349-60.
6. Rechnagel RO, Glende EA Jr. Carbon tetrachloride hepatotoxicity: an example of lethal cleavage. CRC Crit Rev Toxicol 1973;2: 263-97.
7. Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 2003;33:105-36.
8. Raoul JL, Bruix J, Greten TF, Sherman M, Mazzaferro V, Hilgard P, Scherubl H, Scheulen ME, Germanidis G, Dominguez S, Ricci S, Nadel A, Moscovici M, Voliotis D, Llovet JM. Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses. J Hepatol 2012;56:1080-8.
9. Pal M, Ghosh M. Studies on comparative efficacy of α-linolenic acid and α-eleostearic acid on prevention of organic mercuryinduced oxidative stress in kidney and liver of rat. Food Chem Toxicol 2012;50:1066-72.
10. Small DM, Gobe GC. Cytochrome c: potential as a noninvasive biomarker of drug-induced acute kidney injury. Expert Opin Drug Metab Toxicol 2012;8:655-64.
11. Ramadori G, Armbrust T. Cytokines in the liver. Eur J Gastroenterol Hepatol 2001;13:777-84.
12. Diehl AM. Cytokine regulation of liver injury and repair. Immunol Rev 2000;174:160-71.
13. Suliburk JW, Helmer KS, Gonzalez EA, Robinson EK, Mercer DW. Ketamine attenuates liver injury attributed to endotoxemia: role of cyclooxygenase-2. Surgery 2005;138:134-40.
14. Park CM, Youn HJ, Chang HK, Song YS. TOP1 and 2, polysaccharides from Taraxacum officinale, attenuate CCl4-induced hepatic damage through the modulation of NF-κB and its regulatory mediators. Food Chem Toxicol 2010;48:1255-61.
15. Zhao X, Deng X, Park KY, Qiu L, Pang L. Purple bamboo salt has anticancer activity in TCA8113 cells in vitro and preventive effects on buccal mucosa cancer in mice in vivo. Exp Ther Med 2013;5:549-54.
16. Zhao X, Kim SY, Park KY. Bamboo salt has in vitro anticancer activity in HCT-116 cells and exerts anti-metastatic effects in vivo. J Med Food 2013;16:9-19.
17. Delić R, Štefanović M. Optimal laboratory panel for predicting preeclampsia. J Matern Fetal Neonatal Med 2010;23:96-102.
18. Li R, Guo W, Fu Z, Ding G, Zou Y, Wang Z. Hepatoprotective action of Radix Paeoniae Rubra aqueous extract against CCl4induced hepatic damage. Molecules 2011;16:8684-94.
19. Ranawat L, Bhatt J, Patel J. Hepatoprotective activity of ethanolic extracts of bark of Zanthoxylum armatum DC in CCl4 induced hepatic damage in rats. J Ethnopharmacol 2010;127:777-80.
20. Surendran S, Eswaran MB, Vijayakumar M, Rao CV. In vitro and in vivo hepatoprotective activity of Cissampelos pareira against carbon-tetrachloride induced hepatic damage. Indian J Exp Biol 2011;49:939-45.
21. Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis 2006;49:59-75.
22. U.S. Food and Drug Administration [Internet]. Guidance for Industry, Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. Silver Spring (MD): U.S. Food and Drug Administration; 2005 [cited 2013 February 01]. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm078932.pdf.
23. Raju K, Anbuganapathi G, Gokulakrishnan V, Rajkapoor B, Jayakar B, Manian S. Effect of dried fruits of solanum nigrum LINN against CCl4-induced hepatic damage in rats. Biol Pharm Bull 2003;26:1618-9.
24. Segner WP, Schmidt CF, Boltz JK. Effect of sodium chloride and pH on the outgrowth of spores of type E Clostridium botulinum at optimal and suboptimal temperatures Appl Microbiol 1966;14:49-54.
25. Zhao X, Jung OS, Park KY. Alkaline and antioxidant effects of bamboo salt. J Korean Soc Food Sci Nutr 2012;41:1301-4.
26. Tong Y, Yan D, Gao S. Study on sensitive indexes of acute liver damage induced by carbon tetrachloride. Chin J Food Hyg 2000;12:10-1.
27. Wang MY, Anderson G, Nowicki D, Jensen J. Hepatic protection by noni fruit juice against CCl4-induced chronic liver damage in female SD rats. Plant Foods Hum Nutr 2008;63:141-5.
28. Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, Flaker GC, Braunwald E. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1998;98:839-44.
29. Gratacós J, Collado A, Filella X, Sanmartí R, Cañete J, Llena J, Molina R, Ballesta A, Muñoz-Gómez J. Serum cytokines (IL-6, TNF-α, IL-1β and IFN-γ) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 1994;33:927-31.
30. Wang JY, Wang XL, Liu P. Detection of serum TNF-α, IFN-γ, IL-6 and IL-8 in patients with hepatitis B. World J Gastroenterol 1999;5:38-40.
31. Toth B, Yokoyama Y, Schwacha MG, George RL, Rue LW 3rd, Bland KI, Chaudry IH. Insights into the role of interleukin-6 in the induction of hepatic injury after trauma-hemorrhagic shock. J Appl Physiol 2004;97:2184-9.
32. Knight B, Lim R, Yeoh GC, Olynyk JK. Interferon-γ exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury. J Hepatol 2007;47: 826-33.
33. Bradham CA, Plümpe J, Manns MP, Brenner DA, Trautwein C. Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol 1998;275:G387-92.
34. Schümann J, Tiegs G. Pathophysiological mechanisms of TNF during intoxication with natural or man-made toxins. Toxicology 1999;138:103-26.
35. Girish C, Koner BC, Jayanthi S, Rao KR, Rajesh B, Pradhan SC. Hepatoprotective activity of six polyherbal formulations in CCl4induced liver toxicity in mice. Indian J Exp Biol 2009;47:257-63.
36. Manjrekar AP, Jisha V, Bag PP, Adhikary B, Pai MM, Hegde A, Nandini M. Effect of Phyllanthus niruri Linn. treatment on liver, kidney and testes in CCl4 induced hepatotoxic rats. Indian J Exp Biol 2008;46:514-20.
37. Zhao X, Song J, Lee JH, Kim SY, Park KY. Antioxidation and cancer cell (HT-29) antiproliferation effects of Rubus coreanus Miquel bamboo salt. Cancer Prev Res 2010;15:306-12.
38. Halliwell B. Antioxidants: the basics-what they are and how to evaluate them. Adv Pharmacol 1997;38:3-20.
39. Zhao X, Kim SH, Qi YC, Kim SY, Park KY. Effects of different kinds of salt in the comutagenicity and growth of cancer cells. J Korean Soc Food Sci Nutr 2012;41:26-32.
40. Karlsen M, Hovden AO, Vogelsang P, Tysnes BB, Appel S. Bromelain treatment leads to maturation of monocyte-derived dendritic cells but cannot replace PGE2 in a cocktail of IL-1β, IL-6, TNF-α and PGE2. Scand J Immunol 2011;74:135-43.
41. Nan B, Lin P, Lumsden AB, Yao Q, Chen C. Effects of TNF-α and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Thromb Res 2005; 115:417-26.
42. Mills PR, Shenkin A, Anthony RS, McLelland AS, Main AN, MacSween RN, Russell RI. Assessment of nutritional status and in vivo immune responses in alcoholic liver disease. Am J Clin Nutr 1983;38:849-59.
43. Long RG, Meinhard E, Skinner RK, Varghese Z, Wills MR, Sherlock S. Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease. Gut 1978;19:85-90.
44. Yunoki H, Mitsuba K, Noma Y, Ishii N, Kawakami H, Kagawa K, Maruhashi A. Magnesium metabolism in liver disease. Gastroenterol Jpn 1970;5:70.